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Abstract
Aim—To estimate the floor of retinal nerve fibre layer (RNFL) thickness measurements and the 
corresponding retinal sensitivity loss in glaucoma.
Methods—Visual field (VF), Spectralis RNFL (83 patients and 37 healthy subjects) and RTVue 
RNFL data obtained separately (56 patients and 36 healthy subjects) were reviewed. Global and 
quadrant residual layer thicknesses and corresponding VF losses were estimated using two 
Bayesian change point models.
Results—The respective residual thicknesses from change point model 1 (CPM1) on Spectralis 
and RTVue (respectively) were 49.9 and 70.6 μm globally, 57.1 and 83.7 μm superiorly, 55.2 and 
79.0 μm inferiorly, 43.1 and 60.5 μm nasally, and 40.1 and 59.5 μm temporally. Corresponding VF 
losses ranged between −25.1 and −21.7 dB (Spectralis) and between −21.8 and −3.4 dB (RTVue). 
From CPM2, RNFL thinning reached horizontal asymptotes at VF losses between −18.0 and 
−10.7 dB (Spectralis) and between −12.1 and −2.5 dB (RTVue). There were no significant 
differences between postchange point residual layer thicknesses from CPM1 and CPM2 on 
Spectralis (37.0–50.8 μm vs 38.3–56.0 μm) and RTVue (60.6–80.5 μm vs 58.4–88.8 μm).
Conclusions—Global RNFL thinning reaches the floor at a smaller VF loss level with 
Spectralis than with RTVue. The nasal and temporal quadrants retain thinner residual layers than 
superior and inferior quadrant RNFL. Measuring RNFL below their minimums will not yield 
useful clinical information.
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Monitoring glaucoma progression is critical once the diagnosis is made. From a structural 
standpoint, spectral domain optical coherence tomography (SDOCT) allows quantitative 
assessment of peripapillary retinal nerve fibre layer (RNFL) thickness, optic disc topography 
and ganglion cell layer thickness with excellent reproducibility.1–4 Deterioration of these 
structural parameters over time may provide a reliable indication of glaucoma progression.56 
Postmortem histopathological studies have shown residual retinal ganglion cells (RGCs) and 
their axons even after a long-standing advanced glaucoma or glaucoma-induced blindness.7 
Similarly, linear models of the relationship between RNFL thickness and visual field (VF) 
deficit from glaucoma and anterior ischaemic optic neuropathy have predicted the 
persistence of a residual layer following complete loss of RNFL.8–10 In contrast, an 
experimental model predicted a complete loss of RNFL without residual.11
The advent of OCT has renewed the interest in investigating the in vivo residual RNFL 
thickness in eyes with advanced glaucoma or glaucoma-induced blindness. It has been 
determined using time domain (TD) OCT that blind eyes from glaucomatous and non-
glaucomatous optic neuropathies retain a residual RNFL thickness of about 45 μm.1213 
Clinically, this would signify that if interindividual variation is discounted, one cannot use 
average RNFL thickness to monitor glaucoma progression once it has reached 45 μm. This 
has been regarded as the floor of the RNFL thickness or bottom value beyond which no 
further average RNFL thinning can be detected. It is important to know the floor of RNFL 
measurements because it helps define the dynamic range of the instrument’s ability to 
measure RNFL thickness, from completely normal RNFL to the minimum measurable 
thickness. Because SDOCT is currently more widely used than TDOCT, it is important to 
investigate the thickness of the residual layer in glaucoma using SDOCT since the 
algorithms for segmenting retinal layers differ between TDOCT and SDOCT. Two SDOCT-
based studies reported average residual thicknesses of 45.59 and 55.5 μm,14 after averaging 
superior and inferior hemifield values. However, the corresponding VF losses at the time 
RNFL thickness reached the floor were not reported. This is important from a clinical 
perspective because it provides information on the extent of the remaining function once the 
corresponding structure has completely thinned out. This study was designed to estimate the 
floor of global and sectoral RNFL thicknesses and the VF loss at which global and sectoral 
RNFL thinning reach their floor using two different SDOCT devices.
SUBJECTS AND METHODS
Subjects
The medical records of patients with moderate to severe open-angle glaucoma (OAG) were 
reviewed between January 2011 and March 2013 in the Departments of Ophthalmology of 
the University of North Carolina (UNC) and University of California at San Francisco 
(UCSF). OAG was defined based on characteristic glaucomatous optic disc damage with 
accompanying typical glaucomatous VF loss in eyes with open angles on gonioscopy. 
Moderate and severe glaucomas were defined based on VF mean deviation (MD) <−6 dB 
but ≤−12 dB and <−12 dB, respectively.15 In addition, a set of Spectralis OCT (Heidelberg 
Engineering, Heidelberg, Germany) from age-matched normal subjects who participated in 
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an earlier study16 and such RTVue OCT (Optovue, Fremont, California, USA) data from the 
RTVue RNFL normative database along with their VFs were also used in this study.
Exclusion criteria for both glaucoma patients and normal subjects were (1) age below 18 
years; (2) history of or current ocular pathology such as retinal diseases; (3) a history of non-
glaucomatous optic neuropathy, neurological disease or treatment that may lead to optic 
neuropathy; and (4) poor quality scans defined as having quality score <20 (Spectralis) or 
signal strength index <35 (RTVue), algorithm segmentation malfunction and/or motion or 
blinking artefacts. Patients with glaucoma were also excluded if they had a history of 
intraocular surgery within the 3 months preceding OCT scanning. Unreliable VFs (>33% 
fixation losses and false negatives, and >15% fixation losses) were also excluded.
RNFL thickness measurement
Peripapillary RNFL thickness was measured with Spectralis (software V.5.4.6.0, Eye 
Explorer Software V.1.6.1.0) in UNC patients and RTVue (software V.6.1.0.4) in UCSF 
patients using the 3.4 mm scan circle around the optic disc. Only global and quadrant RNFL 
thicknesses were analysed.
Visual field data management
All 52 values from the total deviation numerical plot were used for analysis. To allow for 
assessment of sectoral correlation between VF loss and RNFL thickness, we slightly 
modified the Kanamori and colleagues’ structure–function map17 to obtain only four RNFL 
sectors (figure 1) and four corresponding VF sectors (superior and inferior: 21 data points 
each; temporal: 3 data points; and central: 7 data points) (figure 1). The VF loss of each 
sector was obtained by averaging values of all its data points; the global VF loss was the 
average of all 52 data point total deviations.
Data analysis
Spectralis and RTVue data were analysed separately, and no comparisons were performed 
between data from the two devices because they were obtained in two different groups of 
subjects. The structure–function correlation was assessed by plotting global and sectoral 
RNFL thicknesses against their corresponding total deviation sensitivities. We introduce two 
change point models (CPMs) in the Bayesian setting that attempt to estimate the point of VF 
loss at which the RNFL thinning ends (change point) and the corresponding RNFL thickness 
value. We formally compare the two models globally and sectorally using deviance 
information criterion (DIC),18 a tool used in the Bayesian setting with smaller values being 
preferred and differences ≥7 taken to be significant.
Change point model 1—To estimate the magnitude of VF loss at which the RNFL 
thinning ends, we modified Hood and Kardon’s19 original model and modelled the data 
using a change point regression analysis in the Bayesian setting20 to allow the RNFL 
thickness to level off after a certain value of VF loss, no longer thinning continuously with 
ever-decreasing sensitivity. Additional details on the model and Bayesian statistics in 
general are provided in the online supplementary file.
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Change point model 2—In CPM2, we once again work in the Bayesian setting but 
specify a model for the RNFL thicknesses and corresponding VF loss values on the linear 
scale. This model consists of piecing together two simple linear regression lines at the 
appropriate point (change point). The postchange point line has a slope of zero 
corresponding to no further reduction in the RNFL values. The point at which the two lines 
connect is the change point. We treat this as an unknown parameter in the model and 
estimate it accordingly. The prechange point line has an unknown slope that we also 
estimate using the data. Details regarding this model are also presented in the online 
supplementary file.
To determine whether the measured residual layer thickness differed between the two 
models, we compared (Student t test) CPM1-related and CPM2-related thicknesses obtained 
by averaging all thicknesses with VF losses equal to or worse than the change point. Values 
of p<0.05 indicated statistically significant differences.
RESULTS
Participant characteristics
Participant characteristics are shown in table 1. Patients (n=83, 41 moderate and 42 severe in 
the Spectralis group; and n=56, 36 moderate and 20 severe in the RTVue group) and normal 
subjects (n=37 in the Spectralis group and 36 in the RTVue group) were comparable in age 
(p>0.05), but differed significantly regarding VF MD, all RNFL thicknesses, total deviation 
values (all p<0.001).
Residual thickness and field loss change points
The Bayesian CPM1 analysis estimates of residual layer thickness on Spectralis and RTVue 
were 49.9 and 70.6 μm globally (figure 2), 57.1 and 83.7 μm superiorly, 55.2 and 79.0 μm 
inferiorly, 43.1 and 60.5 μm nasally, and 40.1 and 59.5 μm for temporally (see online 
supplementary figure S2), respectively. The corresponding change points ranged between 
−25.1 and −21.7 dB for residual layers measured with Spectralis and between −21.8 and 
−3.4 dB for residual layers measured with RTVue (table 2).
The Bayesian CPM2 analysis revealed that global and all quadrant RNFL thicknesses 
reached the change point at VF losses ranging from −18.0 to −10.7 dB for RNFL thickness 
measured with Spectralis and from −12.1 to −2.5 dB when RTVue was used (Table 3). Plots 
for global measures are shown in figure 3. Plots for sectoral measures are provided in online 
supplementary figure S3.
The results from formally comparing the model fits from CPM1 and CPM2 are displayed in 
table 4. For Spectralis, CPM1 outperforms CPM2 for the global, superior and nasal sectors. 
In the other sectors, there is no real difference observed in the model fits. For RTVue, the 
model fits are somewhat comparable with neither model being overwhelmingly preferred.
The residual layer thicknesses measured with Spectralis and RTVue obtained by averaging 
all thickness values with VF losses equal to or worse than change points from CPM1 were 
44.8 and 70.0 μm globally, 50.8 and 80.5 μm superiorly, 50.8 and 77.4 μm inferiorly, 37.0 
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and 60.9 μm nasally, and 37.2 and 60.6 μm temporally, respectively (table 5). On both 
Spectralis and RTVue, the superior and inferior residual layers were thicker than the nasal 
and temporal layers (all p<0.001). The corresponding postchange point average VF losses 
ranged between −29.7 and −27.2 dB (Spectralis, all p>0.05) and between −26.5 and −10.9 
dB (RTVue), with greater sensitivity losses globally, superiorly and inferiorly than centrally, 
and temporally for RTVue (table 5). Averaging thickness values with corresponding VF 
losses equal to or greater than the change points from CPM2 resulted in residual thicknesses 
of 48.7 and 71.3 μm globally, 56.0 and 88.8 μm superiorly, 54.2 and 76.8 μm inferiorly, 38.4 
and 58.4 μm temporally, and 38.3 and 60.7 μm nasally, respectively. These values were not 
statistically significantly different from those obtained from CPM1 (all p>0.05, table 5). 
However, differences between corresponding mean VF losses from the two models were 
statistically significant (all p<0.05), except in the temporal field sector (Spectralis and 
RTVue) and the central field sector (RTVue).
DISCUSSION
The change point analyses of the relationship of RNFL as a function of VF loss revealed that 
global and sectoral RNFL thicknesses decrease exponentially before reaching the floor. The 
same trend has been reported both in glaucomatous and non-glaucomatous optic 
neuropathies.8–101419 The structure–function relationship plots from both CPM1 and CPM2 
showed increasing variability of the data with increasing disease severity, so that the 
correlation disappears in the late stage of the disease as reported by others.21 The predicted 
thickness of global residual layer of 49.9 μm (CPM1 analysis on Spectralis data) is 
comparable to 50.5 μm reported by Hood et al,10 but slightly lower than 55.5 μm found by 
Kim et al.14 However, the values in the former study were obtained with TDOCT and were 
only based on the residual layers in the superior and inferior arcuate sectors. Unlike earlier 
studies that only determined the global residual layer thickness, we report for the first time 
global and quadrant residual layer thicknesses.
To the best of our knowledge, the first report on residual layer thickness measured with 
OCT resulted from two analyses performed by Hood.8 In the first analysis, the residual 
thickness of the superior hemifield RNFL was approximately 35 μm with a corresponding 
functional loss of about −10 dB. The second analysis estimated the residual thickness of the 
7 o’clock RNFL sector at 41.6 μm, corresponding to approximately −12 dB. However, these 
estimates were obtained by averaging thicknesses with corresponding VF losses greater than 
the presumed asymptotic point.
Overall our findings agree with the hypothesis that loss of RGC axons leaves a residual layer 
whose thickness is measureable with OCT10 and suggest in addition that the thickness of the 
residual layer varies from sector to sector. This view is at odds with the hypothesis of 
complete loss of axons without residual layer.11 Interestingly, histological studies in primate 
normal eyes have also shown that the proportion of non-axonal content of RNFL varies from 
location to location.22 Another plausible explanation for a residual layer persistence is the 
proliferation of glial content in human retina and optic nerve head after glaucoma-induced 
axonal degeneration.2324
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The global residual layer thickness of 44.8 μm, from averaging all Spectralis postchange 
point RNFL thicknesses from CPM1, is consistent with 44.9 μm measured with TDOCT in 
eyes with glaucoma-induced blindness,13 though none of our patients had complete 
blindness. Similarly, studies with TDOCT in people with non-glaucomatous optic 
neuropathies and vision ranging from 20/200 to no light perception reported residual 
thicknesses between 45.4 and 48.4 μm.1225 In a histological study of 21 eyes enucleated for 
absolute angle-closure glaucoma, the global residual thickness was 40 μm, and the residual 
in the temporal and nasal quadrants (36 μm) was significantly thinner than in the superior 
and inferior quadrants (45 μm).26 The difference in residual thickness among quadrants 
reflects differences in RNFL thickness among sectors in normal subjects. Our interpretation 
is that sectors with thicker RNFL prior to the disease retain a thicker postdisease residual 
layer compared with sectors with thinner RNFL.
Unique to this study is the use of a Bayesian change point analysis, which predicted when 
the RNFL thinning process ends. While statistically CPM1 may be favoured over CPM2 for 
some sectors, CPM2 may be clinically more relevant because of lower VF losses for similar 
residual thicknesses globally and in the superior and inferior quadrants. Interestingly, the 
post-change point residual thicknesses from CPM1 and CPM2 were also similar, with lower 
VF losses in CPM2. The CPM2 results signify, clinically, that in severe glaucoma function 
may continue to deteriorate and to be monitored beyond when RNFL thickness reaches the 
floor. This remaining function suggests the existence of functional axons in the residual 
layer. However, the overall number of these axons does not contribute significantly to the 
thickness of the non-axonal component of the residual layer. This argument aligns with 
evidence of persisting RGCs and their axons in blind eyes enucleated for glaucoma.7
Although Spectralis and RTVue data were obtained in different groups of subjects, it was 
surprising that the RTVue data predicted thicker residuals than Spectralis. This may be 
related to the difference in segmentation algorithms on the two devices, RTVue being 
known to compute thicker measurements than Spectralis.27 Additionally, in both models the 
change point 95% CI were generally wider for RTVue, likely resulting from (1) 
misalignment of RTVue scan circles due to the lack of eye tracking during image acquisition 
compared with Spectralis28 and (2) the narrower VF data dynamic range in RTVue patients. 
This may have reduced the change point prediction accuracy for RTVue.
In summary, RNFL thinning in glaucoma reaches the floor earlier than functional loss. The 
nasal and temporal quadrants retain thinner residual layers than superior and inferior 
quadrants. Caution is needed before applying the RNFL floor values reported herein to 
individual subjects because the actual floor may be different due to interindividual 
variability of RNFL thickness prior to the disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structure–function map between retinal nerve fibre layer sectors (left) and corresponding 
visual field sectors (right).
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Plots of the Bayesian change point analyses (model 1) of the relationship of global retinal 
nerve fibre layer (RNFL) thickness from Spectralis and RTVue with global retinal 
sensitivity loss. The plain thick curve represents the course of the predicted RNFL thinning 
as a function of retinal sensitivity loss; the dotted lines are the upper and lower 95% credible 
intervals. VF, visual field.
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Plots of the Bayesian change point analyses (model 2) of the relationship of global retinal 
nerve fibre layer (RNFL) thickness from Spectralis and RTVue with global retinal 
sensitivity loss. The point at which the two plain thick lines connect is the change point. The 
dotted lines are the upper and lower 95% credible intervals. VF, visual field.
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Table 2
Predicted residual layer thickness and corresponding sensitivity loss (change point) from change point model 1
Residual layer (μm)* VF loss (dB) (change point)
Spectralis OCT
 Global 49.9 (48.0 to 51.9) −25.1 (−31.8 to −16.1)
 Superior quadrant 57.1 (53.8 to 60.5) −24.8 (−32.4 to −14.8)
 Inferior quadrant 55.2 (52.3 to 58.2) −24.9 (−31.5 to −15.8)
 Temporal quadrant 40.1 (37.3 to 42.8) −24.4 (−33.5 to −13.0)
 Nasal quadrant 43.1 (39.8 to 46.4) −21.7 (−30.8 to −10.0)
RTVue OCT
 Global 70.6 (67.5 to 74.1) −18.9 (−27.9 to −8.1)
 Superior quadrant 83.7 (77.1 to 91.0) −18.1 (−29.2 to −3.9)
 Inferior quadrant 79.0 (75.0 to 83.0) −21.8 (−29.9 to −11.4)
 Temporal quadrant 59.5 (53.8 to 64.1) −6.7 (−29.4 to −1.3)
 Nasal quadrant 60.5 (55.8 to 64.1) −3.4 (−17.8 to −1.1)
*
Values represent posterior means from the Bayesian change point analyses; values in parentheses indicate lower and upper 95% credible intervals.
OCT, optical coherence tomography; VF, visual field.
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Table 3
Predicted residual layer thickness and corresponding sensitivity loss (change point) from change point model 2
Residual layer (μm)* VF loss (dB) (change point)
Spectralis OCT
 Global 48.8 (46.1 to 51.4) −10.7 (−12.3 to −9.4)
 Superior quadrant 56.0 (50.7 to 60.9) −11.4 (−14.3 to −8.6)
 Inferior quadrant 54.3 (50.1 to 58.4) −11.5 (−14.0 to −8.8)
 Temporal quadrant 38.2 (34.1 to 41.7) −12.8 (−18.2 to −9.2)
 Nasal quadrant 38.1 (30.2 to 44.2) −18.0 (−29.4 to −9.7)
RTVue OCT
 Global 71.5 (67.6 to 75.0) −8.5 (−11.8 to −5.2)
 Superior quadrant 87.4 (76.6 to 93.7) −5.6 (−12.7 to −2.8)
 Inferior quadrant 77.3 (71.8 to 82.6) −12.1 (−16.3 to −8.4)
 Temporal quadrant 58.6 (45.9 to 64.2) −8.4 (−29.3 to −2.2)
 Nasal quadrant 61.0 (57.4 to 64.3) −2.5 (−5.9 to −0.2)
*
Values represent posterior means from the Bayesian change point analyses; values in parentheses indicate lower and upper 95% credible intervals.
OCT, optical coherence tomography; VF, visual field.
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Table 4
Model comparison using deviance information criterion
Change point model 1 Change point model 2
Spectralis OCT
 Global 843.7 851.2
 Superior quadrant 963.4 970.2
 Inferior quadrant 926.8 925.9
 Temporal quadrant 913.1 914.5
 Nasal quadrant 945.4 960.6
RTVue OCT
 Global 690.8 692.0
 Superior quadrant 788.2 787.7
 Inferior quadrant 703.3 701.2
 Temporal quadrant 724.5 728.2
 Nasal quadrant 741.6 747.1
OCT, optical coherence tomography.










































































































































































































































































































































































































































































































































































































































































































































































































































































































































Br J Ophthalmol. Author manuscript; available in PMC 2016 June 01.
